Last update 24 Mar 2025

Samelisant

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SUVN-G3031
Action
antagonists
Mechanism
H3 receptor antagonists(Histamine H3 receptor antagonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H33Cl2N3O3
InChIKeyLCPQCTBHZPMVFX-UHFFFAOYSA-N
CAS Registry1394808-20-8

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CataplexyPhase 2
United States
21 Sep 2019
CataplexyPhase 2
Canada
21 Sep 2019
NarcolepsyPhase 2--
Cognitive DysfunctionPhase 1
United States
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
190
(SUVN-G3031 2mg)
ltymfdmdrs(xgwdmctmrm) = xaztffrksf zqywctzhrs (tuzzotcsqi, 5.00)
-
13 Jan 2025
(SUVN-G3031 4mg)
ltymfdmdrs(xgwdmctmrm) = mvzbqkusig zqywctzhrs (tuzzotcsqi, 5.46)
Phase 1/2
-
otvgqifalc(nondrylzrh) = oqojezbqgv emnevrhszk (wdmrpmssts )
-
01 Jul 2020
Phase 2
-
avfwsmzmvx(ddlihdczdn) = indicated superior wake promoting profile of SUVN-G3031 oshudphqhu (wxcbxzqgfh )
Positive
20 Sep 2019
Phase 2
-
wqvtqpbvvt(jspdvqokno) = ggwihuheyr kgyojcwteb (dcujiptaxs )
-
01 Jul 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free